ArticleThe oncologist2025

Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countries.

Oscar Arrieta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.